Home » Newsletters » BioWorld Science

BioWorld Science

March 28, 2022

View Archived Issues

Identification of sites of metabolic liability for KRM-II-81 and evaluation of a deuterated analogue

Variant in the CTR1 gene causes novel disorder of copper metabolism

MK-6158: sGC stimulator clinical candidate for pulmonary arterial hypertension

Novel nonhallucinogenic DMT analogues as drug candidates for mental health and addiction disorders

Phosphatidylserine is crucial for synaptic pruning in adult-born neurons

New antibacterials identified at Roche

Yale University divulges new oligosaccharyltransferase complex inhibitors

HDAC inhibitors disovered at Chong Kun Dang Pharmaceutical

Dompe Farmaceutici describes new peptides with angiogenic activity

Bayer patents P2X purinoceptor 4 antagonists

Novel USP30 inhibitors as potential anti-Parkinson candidates

Novartis details discovery, preclinical data of novel antimalarial compound INE-963

Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH

Missense variants in DDX39B linked to novel syndrome of global neurodevelopmental delay

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...